78 related articles for article (PubMed ID: 694200)
1. H-2 typing of RBL-5, TLX/9 tumour cells and L929 fibroblast.
Garrido F; Pérez M; Osorio C
Rev Esp Fisiol; 1978 Jun; 34(2):137-43. PubMed ID: 694200
[TBL] [Abstract][Full Text] [Related]
2. Characterization of antigens on murine tumor cells reacting with alloantisera against foreign H-2 specificities: analysis by absorption with purified murine leukemia virus and normal lymphoid cells of different H-2 haplotypes.
Schirrmacher V; Marxen I; Robinson P
Z Immunitatsforsch Immunobiol; 1978 Dec; 155(2):155-68. PubMed ID: 85374
[TBL] [Abstract][Full Text] [Related]
3. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. I. H-2-encoded dominant gene control.
Green WR
J Immunol; 1984 May; 132(5):2658-64. PubMed ID: 6425409
[TBL] [Abstract][Full Text] [Related]
4. Immunogenetic studies of H-2 antigens of MCG 3 tumour cells.
Torres MD; Gutiérrez F; Rueda G; Osorio C
Rev Esp Fisiol; 1981 Jun; 37(2):173-6. PubMed ID: 7313274
[TBL] [Abstract][Full Text] [Related]
5. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
Tremblay N; Fontaine P; Perreault C
Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
[TBL] [Abstract][Full Text] [Related]
6. Specificity of cytolytic T cells directed against AKR/Gross virus-induced syngeneic leukemias: antibodies directed against H-2K, but not against viral proteins, inhibit lysis.
Green WR; Nowinski RC; Henney CS
J Immunol; 1980 Aug; 125(2):647-55. PubMed ID: 6156211
[No Abstract] [Full Text] [Related]
7. [Humoral autoimmune reactions directed against autoantigens of the H-2 histocompatibility system in mice with developing Rauscher leukemia].
Ter-Griggorov VS; Moskovkina OIa; Krupnik VE; Graf IA; Pivnik AV
Eksp Onkol; 1988; 10(6):21-5. PubMed ID: 2468468
[TBL] [Abstract][Full Text] [Related]
8. Purification of a glycoprotein bearing a tumor transplantation antigen specific for Friend, Moloney, and Rauscher MuLV-induced tumors.
Rogers MJ; Galetto G; Hearing VJ; Siwarski DF; Law LW
J Immunol; 1984 Jun; 132(6):3211-7. PubMed ID: 6202777
[TBL] [Abstract][Full Text] [Related]
9. Recognition of H-2Kb mutant target cells by Moloney virus-specific cytotoxic T lymphocytes from bm13 (H-2Db mutant) mice. I. Full recognition of Kbm11 by Kb-restricted CTL.
Stukart MJ; Boes J; Melief CJ
J Immunol; 1984 Jul; 133(1):24-7. PubMed ID: 6202782
[TBL] [Abstract][Full Text] [Related]
10. Detection of a unique antigen on radiation leukemia virus-induced leukemia B6RV2.
Nakayama E; Uenaka A; Stockert E; Obata Y
Cancer Res; 1984 Nov; 44(11):5138-44. PubMed ID: 6091870
[TBL] [Abstract][Full Text] [Related]
11. Association between H-2 and vaccinia virus-induced antigens on the surface of infected cells.
Senik A; Neauport-Sautes C
J Immunol; 1979 Apr; 122(4):1461-7. PubMed ID: 448095
[TBL] [Abstract][Full Text] [Related]
12. H-2 antigens and tumour-associated transplantation antigens in clones derived from a methylcholanthrene-induced BALB/c tumour: their influence on the generation in vitro and in vivo of the specific anti-tumour immune response.
Pérez M; Garrido A; Algarra I; Caballero A; Delgado C; Collado MD; Fernández-Cruz E; Garrido F
Exp Clin Immunogenet; 1989; 6(3):204-18. PubMed ID: 2631798
[TBL] [Abstract][Full Text] [Related]
13. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. II. Negative control by the Fv-1 locus in AKR mice of responder H-2b haplotype.
Green WR
J Immunol; 1984 May; 132(5):2665-71. PubMed ID: 6425410
[TBL] [Abstract][Full Text] [Related]
14. The in vitro generation of H-2-restricted cytotoxic T cells to AKR/Gross leukemia virus-induced tumors. I. Requirement for stimulation with allogeneic leukemia cells in vivo.
Green WR
J Immunol; 1982 Mar; 128(3):1043-9. PubMed ID: 6976986
[No Abstract] [Full Text] [Related]
15. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
Green WR
J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
[TBL] [Abstract][Full Text] [Related]
16. Serological analysis of H-2 antigens expression on the cell surface of selected mouse tumors.
Opolski A; Radzikowski C
Arch Immunol Ther Exp (Warsz); 1986; 34(1):7-17. PubMed ID: 3778116
[TBL] [Abstract][Full Text] [Related]
17. Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivo.
Truitt RL; Shih CY; Lefever AV; Tempelis LD; Andreani M; Bortin MM
J Immunol; 1983 Oct; 131(4):2050-8. PubMed ID: 6194224
[TBL] [Abstract][Full Text] [Related]
18. Effector mechanisms of syngeneic anti-tumour responses in mice. I. Establishment and characterization of an exogenous IL-2-independent cytotoxic T-lymphocyte line specific for radiation-induced leukaemia RL male 1.
Kuribayashi K; Keyaki A; Sakaguchi S; Masuda T
Immunology; 1985 Sep; 56(1):127-40. PubMed ID: 3876271
[TBL] [Abstract][Full Text] [Related]
19. Characterization of H-2Db antigens implies haplotype differences in the number of H-2 molecules expressed.
Melino MR; Nichols EA; Strausser HR; Hansen TH
J Immunol; 1982 Jul; 129(1):222-6. PubMed ID: 6177750
[TBL] [Abstract][Full Text] [Related]
20. Recognition of H-2Kb mutant target cells by Moloney virus-specific cytotoxic T lymphocytes from bm13 (H-2Db-mutant) mice. II. Relationship of Kbm3 and Kbm11 in restriction specificities and allodeterminants.
Stukart MJ; Boes J; Melief CJ
J Immunol; 1984 Jul; 133(1):28-32. PubMed ID: 6202783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
